Perioperative blood loss after abdominal myomectomies: new solutions to an old problem

Seracchioli, Renato; Esposti, E. Degli; Arena, Alessandro

doi:10.1016/j.fertnstert.2021.01.002

Cited by 1 publication

(2 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In fact, the potential risk of heavy bleeding during surgery and preventing strategies remains a major concern for both anesthesiologists and surgeons. 18 However, the results of previous studies on the best option for this purpose are not consistent. 14 It has recently been argued that performing myomectomy by the preservation of the pseudocapsule results in less bleeding even in laparotomy.…”

Section: Discussionmentioning

confidence: 92%

“…Another drug that could effectively control bleeding during abdominal myomectomy was carbetocin, which is a long‐acting analog of oxytocin. In fact, the potential risk of heavy bleeding during surgery and preventing strategies remains a major concern for both anesthesiologists and surgeons 18 . However, the results of previous studies on the best option for this purpose are not consistent 14 .…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Safety and efficacy of lidocaine plus epinephrine on intraoperative bleeding in abdominal myomectomy: A double‐blind clinical trial

Mansour‐Ghanaei

Hosseinzadeh

Sharami

et al. 2022

Health Science Reports

View full text Add to dashboard Cite

Background Uterine fibroid is a common benign pelvic tumor and abdominal myomectomy may cause excessive intraoperative bleeding, which may lead to adverse outcomes. Objective This study was planned to evaluate the effectiveness of the injection of lidocaine plus epinephrine to reduce intraoperative bleeding in abdominal myomectomy. Methods During October 2019 and May 2020, 60 eligible women with uterine fibroids were enrolled in a randomized controlled trial. Our patients were divided into two groups of lidocaine plus epinephrine defined as Group L and placebo defined as Group P. In group L, lidocaine 3 mg/kg plus 0.5 ml of adrenaline which reached to 50 cc with saline solution and in group P, 50 ml of normal saline was used. Both the combined solution and normal saline were infiltrated to the serous and myometrium above and around the fibroid before incision. Patients' demographic data, total operative time, hemoglobin changes, and the degree of surgical difficulty were evaluated and compared between the two groups. Results There was no significant difference between the two groups in terms of demographic data. Hemoglobin changes ( p 0.0001) and the degree of surgery difficulty ( p = 0.01) were significantly lower in Group L compared with Group P. In each group the drop in hemoglobin levels from baseline to 4 h postoperatively was significant ( p 0.0001). A significantly meaningful correlation was reported between hemoglobin changes and the degree of surgery difficulty with the size of the uterine and fibroids ( p < 0.05). While a negative correlation was found regarding gravidity and surgery difficulty ( r = −0.413, p = 0.02). Surgery duration was longer in Group P compared with Group L 70.66 ± 19.85 versus 66.16 ± 14.48, respectively, but with no significant difference ( p = 0.32). No significant adverse reaction or serious complication was reported in the two groups. Hemodynamic parameters were kept in the normal range throughout the surgery. Conclusion A combination of lidocaine plus epinephrine during abdominal myomectomy appears to be a safe and effective method in reducing blood loss.

show abstract

Section: Discussionmentioning

confidence: 92%

Section: Discussionmentioning

confidence: 99%